A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly diseases is starting human clinical testing. Read More
As coronavirus vaccines are distributed throughout the country, a big question remains: Even though the vaccines reduce symptomatic COVID-19, can… Read More
PATH, the Seattle-based global heath nonprofit, is opening a new Center for Vaccine Innovation and Access, funded initially through an $11 million… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.